Laboratorios Farmaceuticos ROVI SA LABFF
$67.17
Last Updated: Aug 03, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
LABFF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Laboratorios Farmaceuticos ROVI SA is classified as halal.
HALAL
Report Source: undefined Quarter Report
Laboratorios Farmaceuticos ROVI SA. Stock Analysis LABFF
United States Health Care Mid Cap Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. The company employs 2,216 full-time employees The company went IPO on 2007-10-26. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The firm owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.
Laboratorios Farmaceuticos ROVI SA (LABFF) Chart
Financial Metrics & Statements of Laboratorios Farmaceuticos ROVI SA (LABFF)
FAQ's for Laboratorios Farmaceuticos ROVI SA (LABFF)
- As of August 2026, Laboratorios Farmaceuticos ROVI SA LABFF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Laboratorios Farmaceuticos ROVI SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Laboratorios Farmaceuticos ROVI SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Laboratorios Farmaceuticos ROVI SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Laboratorios Farmaceuticos ROVI SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Laboratorios Farmaceuticos ROVI SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Laboratorios Farmaceuticos ROVI SA (LABFF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
